JAMES BRITT: Open Payments
NPI 1578348710 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 35 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $446 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 5 | $87 |
| Merck Sharp & Dohme LLC | 5 | $77 |
| SCPHARMACEUTICALS INC. | 4 | $76 |
| PFIZER INC. | 3 | $54 |
| Novo Nordisk Inc | 2 | $48 |
| Amgen Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| HEARTFLOW, INC. | 1 | $26 |
Products named: Kerendia, LEQVIO, FUROSCIX, ELIQUIS, VERQUVO, Wegovy, REPATHA, JARDIANCE.
Industry payments across SC — which companies pay providers there.
